1Sharareh Eskandarieh, 1Mohammad Ali Sahraian, 1Saeideh Ayoubi 1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran Background: The Middle-east and North Africa (MENA) region had a high prevalence of MS between 1970 and 2015 (1-2). Iran had the highest prevalence of MS among the countries of the Eastern Mediterranean region (72.11/100000)…
1Sharareh Eskandarieh, 1Seyyed Hosein Mortazavi, 2Amir Almasi-Hashiani, 1Abdorreza Naser Moghadasi, 1Mohammad Ali Sahraian 1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran; 2Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran Background: Multiple sclerosis is a chronic central nervous system disease and primary progressive multiple sclerosis (PPMS)…
5Hayder K Hassoun, 1Akram Al Mahdawi, 2Nawfal Shaheed, 3Amanj Jamal, 4Sara Sami 1Faculty of Medicine, Baghdad University, Baghdad, Iraq; 2Baghdad Teaching Hospital, Baghdad, Iraq; 3Hawler Teaching Hospital, Erbil, Iraq; 4Marjan teaching hospital, bayblon, Iraq; 5Faculty of Medicine, Kufa University, Annajaf Al ashraf, Iraq Background: Multiple sclerosis (MS) is a progressive demyelinating and degenerative disease of…
1Anwaar Mukhtar Bennour, 1Majda Elshukri, 1Naziha Amer, 1Heba Elzawawi, 1Rabha Elsahli, 1Abdelhamid Elzawawi 1Benghazi Medical Center, Benghazi, Libya Background: There are many misconceptions about multiple sclerosis (MS) and pregnancy with issues surrounding disease modifying therapies (DMTs) remains a regular subject of discussion. Objective(s): To explore a local practice experience regarding management of women with MS…
1,2Raed Alroughani, 3,4Jasem Al-Hashel, 3Fathi Abokalawa, 4Malak Almojel, 3,5Samar Farouk Ahmed 1Amiri Hospital, Kuwait City, Kuwait; 2MS clinic, Ibn Sina Hospital, Kuwait City, Kuwait; 3Neurology Department, Ibn Sina hospital, Kuwait City, Kuwait; 4Kuwait University, Kuwait City, Kuwait; 5Minia University, Minia, Egypt Background: Two vaccine (BNT162b2 and ChAdOx1 nCoV-19) have been approved to be used in…
1Raed Alroughani, 2Jihad Said Inshasi, 3Jasem Al-Hashel, 4Jaber Alkhaboury, 4Abdullah Alsalti, 2Reem Al Suwaidi, 5Loqman H. Hassino, 6,7Samar Farouk Ahmed 1Division of Neurology, Department of Medicine, Amiri Hospital, Kuwait City, Kuwait; 2Neurology Department, Rashid Hospital and Dubai Medical College, Dubai, United Arab Emirates; 3Faculty of Medicine, Kuwait University, Kuwait City, Kuwait; 4Neurology Unit, College of…
1Sharareh Eskandarieh, 1Niloofar Jahromi, 1Narges Systena, 1Mohhamed Ali Sahraian 1Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran Background: Multiple sclerosis (MS) is a debilitating non-traumatic neurological disorder in young adults and can reduce quality of life (QoL) by interfering with work ability, leisure activities, and routine living tasks (1). Various…
1Seyedmohammad Baghbanian, 1Hadis Alinejad, 2Sharareh Eskandarieh, 2Mohammadali Sahraian 1Mazandaran University Of Medical Sciences, Sari, Iran; 2Tehran University Of Medical Sciences, Tehran, Iran Background/Objective(s): Mazandaran is a Caspian province in the north of Iran and with a population of more than three million people. The Mazanderani people’s ancestors came from the Caucasus region, perhaps displacing an…
1Roshanak Mehdipour Dastjerdi, 1Fereshteh Ashtari 1Isfahan University of Medical Sciences, Isfahan, Iran; 2Isfahan Neurosciences Research Center, Isfahan, Iran Background: The knowledge about gender based different characteristics of multiple sclerosis (MS) is important to find new strategies for further managing and treatment. On the other hand patientĖs sex can be an important risk factor for incidence…
1Christos Bakirtzis, 1Marina – Kleopatra Boziki, 1Eleni Grigoriadou, 1Evangelia Kesidou, 1Ioannis Nikolaidis, 1Styliani-Aggeliki Sintila, 2Theodoros Moysiadis, 2Dimitra Tsakona, 3Georgios Papazisis, 1Nikolaos Grigoriadis 1Multiple Sclerosis Center, B’ Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece; 2Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece; 3Department of Clinical Pharmacology, Aristotle University of Thessaloniki,…